Autor: "D'Haens, Geert" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Clinical statistical analysis plan for the ACCURE trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicentre trial.
Autorzy:: Visser E; Department of Surgery, Amsterdam University Medical Centre, Amsterdam, The Netherlands. .
Heuthorst L; Department of Surgery, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
Pathmakanthan S; Department of Gastroenterology, Queen Elizabeth University Hospital Birmingham, Birmingham, UK.
Bemelman WA; Department of Surgery, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
D'Haens GR; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centre, Amsterdam, the Netherlands.
Handley K; University of Birmingham Clinical Trials Unit, Birmingham, UK.
Fakis A; Derby Clinical Trials Support Unit, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.
Pinkney TD; Academic Department of Surgery, University of Birmingham, Birmingham, UK.
Buskens CJ; Department of Surgery, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
Dijkgraaf MGW; Department of Epidemiology and Data Science, University Medical Centre, Amsterdam, the Netherlands.; Methodology, Amsterdam Public Health, Amsterdam, the Netherlands.; Pokaż więcej
Źródło:: Trials [Trials] 2024 Mar 26; Vol. 25 (1), pp. 218. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:: Randomized Controlled Trial; Multicenter Study; Journal Article
MeSH Terms:: Colitis, Ulcerative*/drug therapy
Humans ; Appendectomy ; Quality of Life ; Remission Induction ; Neoplasm Recurrence, Local ; Mesalamine ; Recurrence ; Disease Progression

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.
Autorzy:: van Dam KPJ; Department of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.
Volkers AG; Department of Gastroenterology and Hepatology, Location Academic Medical Center, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Wieske L; Department of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.; Department of Clinical Neurophysiology, St Antonius Hospital, Nieuwegein, The Netherlands.
Stalman EW; Department of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.
Kummer LYL; Department of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands.
van Kempen ZLE; Department of Neurology, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands.
Killestein J; Department of Neurology, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands.
Tas SW; Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Department of Rheumatology and Clinical Immunology, University of Amsterdam, Amsterdam, the Netherlands.
Boekel L; Amsterdam Rheumatology and Immunology Center, Location Reade, Department of Rheumatology, Amsterdam, the Netherlands.
Wolbink GJ; Amsterdam Rheumatology and Immunology Center, Location Reade, Department of Rheumatology, Amsterdam, the Netherlands.
van der Kooi AJ; Department of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.
Raaphorst J; Department of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.
Takkenberg RB; Department of Gastroenterology and Hepatology, Location Academic Medical Center, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
D'Haens GRAM; Department of Gastroenterology and Hepatology, Location Academic Medical Center, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Spuls PI; Department of Dermatology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Bekkenk MW; Department of Dermatology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Musters AH; Department of Dermatology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Post NF; Department of Dermatology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Bosma AL; Department of Dermatology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Hilhorst ML; Department of Internal Medicine, Section of Nephrology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Vegting Y; Department of Internal Medicine, Section of Nephrology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Bemelman FJ; Department of Internal Medicine, Section of Nephrology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Voskuyl AE; Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, VU University Medical Center, Amsterdam, the Netherlands.
Broens B; Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, VU University Medical Center, Amsterdam, the Netherlands.
Sanchez AP; Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Department of Rheumatology and Clinical Immunology, University of Amsterdam, Amsterdam, the Netherlands.; Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, VU University Medical Center, Amsterdam, the Netherlands.
van Els CACM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.; Faculty of Veterinary Medicine, Utrecht University Utrecht, Utrecht, The Netherlands.
de Wit J; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Rutgers A; Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands.
de Leeuw K; Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands.
Horváth B; Department of Dermatology, Center for Blistering Diseases, University Medical Center Groningen, University Groningen, Groningen, The Netherlands.
Verschuuren JJGM; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Ruiter AM; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
van Ouwerkerk L; Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.
van der Woude D; Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.
Allaart RCF; Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.
Teng YKO; Centre of Expertise for Lupus-, Vasculitis- and Complement-Mediated Systemic Diseases, Department of Internal Medicine - Nephrology section, Leiden University Medical Centre, Leiden, The Netherlands.
van Paassen P; Department of Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, The Netherlands.
Busch MH; Department of Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, The Netherlands.
Jallah PBP; Department of Nephrology and Clinical Immunology, Maastricht University Medical Center, Maastricht, The Netherlands.
Brusse E; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
van Doorn PA; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Baars AE; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Hijnen DJ; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Schreurs CRG; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
van der Pol WL; Department of Neurology and Neurosurgery, Brain Center UMC Utrecht, Utrecht, the Netherlands.
Goedee HS; Department of Neurology and Neurosurgery, Brain Center UMC Utrecht, Utrecht, the Netherlands.
Steenhuis M; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands.
Keijzer S; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands.
Keijser JBD; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands.
Cristianawati O; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands.
Ten Brinke A; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands.
Verstegen NJM; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands.
van Ham SM; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands.; Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, the Netherlands.
Rispens T; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, the Netherlands.
Kuijpers TW; Department of Pediatric Immunology, Rheumatology and Infectious Disease, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, the Netherlands.
Löwenberg M; Department of Gastroenterology and Hepatology, Location Academic Medical Center, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Eftimov F; Department of Neurology and Neurophysiology, Amsterdam Neuroscience, Amsterdam UMC, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands. .; Pokaż więcej
Corporate Authors:: T2B! Immunity against SARS-CoV-2 study group
Źródło:: BMC infectious diseases [BMC Infect Dis] 2023 May 17; Vol. 23 (1), pp. 332. Date of Electronic Publication: 2023 May 17.
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*
Humans ; SARS-CoV-2 ; Immunity, Humoral ; Prospective Studies ; Tumor Necrosis Factor Inhibitors ; Immunosuppressive Agents/therapeutic use ; Tumor Necrosis Factor-alpha ; Vaccination ; Antibodies, Viral

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Validation Study of Novel Point-of-Care Tests for Infliximab, Adalimumab and C-Reactive Protein in Capillary Blood and Calprotectin in Faeces in an Ambulatory Inflammatory Bowel Disease Care Setting.
Autorzy:: Volkers A; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Löwenberg M; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Braad M; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Abeling Y; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Gecse K; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Berkers N; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Montazeri N; Biostatistics Unit, Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
D'Haens G; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.; Pokaż więcej
Źródło:: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2023 May 12; Vol. 13 (10). Date of Electronic Publication: 2023 May 12.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Tofacitinib for the Treatment of Ulcerative Colitis: An Integrated Summary of up to 7.8 Years of Safety Data from the Global Clinical Programme.
Autorzy:: Sandborn WJ; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
D'Haens GR; Department of Gastroenterology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Sands BE; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Panaccione R; Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, AB, Canada.
Ng SC; Institute of Digestive Disease, Department of Medicine and Therapeutics, LKS Institute of Health Science, Chinese University of Hong Kong, Hong Kong.
Lawendy N; Pfizer Inc, Collegeville, PA, USA.
Kulisek N; Pfizer Inc, Collegeville, PA, USA.
Modesto I; Pfizer Inc, New York, NY, USA.
Guo X; Pfizer Inc, Collegeville, PA, USA.
Mundayat R; Pfizer Inc, New York, NY, USA.
Su C; Pfizer Inc, Collegeville, PA, USA.
Vranic I; Pfizer Ltd, Tadworth, Surrey, UK.
Panés J; Department of Gastroenterology, Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.; Pokaż więcej
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2023 Apr 03; Vol. 17 (3), pp. 338-351.
Typ publikacji:: Clinical Trial; Journal Article
MeSH Terms:: Colitis, Ulcerative*/complications
Herpes Zoster*/chemically induced
Herpes Zoster*/epidemiology
Janus Kinase Inhibitors*/adverse effects
Opportunistic Infections*/epidemiology
Skin Neoplasms*
Humans ; Protein Kinase Inhibitors/adverse effects ; Pyrroles/adverse effects ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Benefit of Risk-stratified Prophylactic Treatment on Clinical Outcome in Postoperative Crohn's Disease.
Autorzy:: Joustra V; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, AGEM University of Amsterdam, Amsterdam, The Netherlands.
van Sabben J; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, AGEM University of Amsterdam, Amsterdam, The Netherlands.
van der Does de Willebois E; Department of Surgery, Amsterdam University Medical Centers, AGEM University of Amsterdam, Amsterdam, The Netherlands.
Duijvestein M; Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, The Netherlands.
de Boer N; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism [AGEM] Research Institute, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
Jansen J; Department of Gastroenterology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
van der Bilt J; Department of Surgery, Amsterdam University Medical Centers, AGEM University of Amsterdam, Amsterdam, The Netherlands.
Lameris W; Department of Surgery, Amsterdam University Medical Centers, AGEM University of Amsterdam, Amsterdam, The Netherlands.
Bemelman W; Department of Surgery, Amsterdam University Medical Centers, AGEM University of Amsterdam, Amsterdam, The Netherlands.
Buskens C; Department of Surgery, Amsterdam University Medical Centers, AGEM University of Amsterdam, Amsterdam, The Netherlands.
D'Haens G; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, AGEM University of Amsterdam, Amsterdam, The Netherlands.; Pokaż więcej
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2023 Apr 03; Vol. 17 (3), pp. 318-328.
Typ publikacji:: Journal Article
MeSH Terms:: Crohn Disease*/drug therapy
Crohn Disease*/prevention & control
Crohn Disease*/surgery
Humans ; Colonoscopy ; Retrospective Studies ; Colectomy/adverse effects ; Cecum/surgery ; Recurrence ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Systematic Review and Meta-analysis of Peripheral Blood DNA Methylation Studies in Inflammatory Bowel Disease.
Autorzy:: Joustra V; Amsterdam UMC location University of Amsterdam, Department of Gastroenterology and Hepatology, Meibergdreef 9, Amsterdam, Netherlands.; Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, Netherlands.
Hageman IL; Amsterdam UMC location University of Amsterdam, Department of Gastroenterology and Hepatology, Meibergdreef 9, Amsterdam, Netherlands.; Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, Netherlands.; Amsterdam UMC location University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, Amsterdam, Netherlands.
Satsangi J; Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
Adams A; Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
Ventham NT; Institute of Genetics and Molecular Medicine, University of Edinburgh, UK.
de Jonge WJ; Amsterdam UMC location University of Amsterdam, Department of Gastroenterology and Hepatology, Meibergdreef 9, Amsterdam, Netherlands.; Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, Netherlands.; Amsterdam UMC location University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, Amsterdam, Netherlands.
Henneman P; Amsterdam UMC location University of Amsterdam, Department of Human Genetics, Genome Diagnostics Laboratory, Amsterdam, Netherlands.; Amsterdam Reproduction & Development, Amsterdam, Netherlands.
D'Haens GR; Amsterdam UMC location University of Amsterdam, Department of Gastroenterology and Hepatology, Meibergdreef 9, Amsterdam, Netherlands.; Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, Netherlands.
Li Yim AYF; Amsterdam UMC location University of Amsterdam, Department of Gastroenterology and Hepatology, Meibergdreef 9, Amsterdam, Netherlands.; Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, Netherlands.; Amsterdam UMC location University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, Amsterdam, Netherlands.; Amsterdam UMC location University of Amsterdam, Department of Human Genetics, Genome Diagnostics Laboratory, Amsterdam, Netherlands.; Amsterdam Reproduction & Development, Amsterdam, Netherlands.; Pokaż więcej
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2023 Mar 18; Vol. 17 (2), pp. 185-198.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Inflammatory Bowel Diseases*/genetics
Crohn Disease*/genetics
Colitis, Ulcerative*/genetics
Humans ; DNA Methylation ; Cross-Sectional Studies ; Membrane Proteins/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance.
Autorzy:: Colman RJ; Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatric Gastroenterology and Nutrition, Amsterdam University Medical Centers - Location University of Amsterdam, Emma Children's Hospital, Amsterdam, The Netherlands.
Mizuno T; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Fukushima K; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Haslam DB; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Hyams JS; Division of Digestive Diseases, Hepatology and Nutrition, Connecticut Children's Medical Center, Cincinnati, Ohio, USA.
Boyle B; Division of Gastroenterology, Hepatology and Nutrition, Nationwide Children's Hospital, Columbus, Ohio, USA.
Noe JD; Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Wisconsin, Wauwatosa, Wisconsin, USA.
D'Haens GR; Gastroenterology and Hepatology, Amsterdam University Medical Centers - Location University of Amsterdam, Amsterdam, The Netherlands.
Van Limbergen J; Department of Pediatric Gastroenterology and Nutrition, Amsterdam University Medical Centers - Location University of Amsterdam, Emma Children's Hospital, Amsterdam, The Netherlands.; Tytgat Institute for Liver and Intestinal Research, Amsterdam Gastroenterology Endocrinology Metabolism, University of Amsterdam, Amsterdam, The Netherlands.
Chun K; Esoterix, LabCorp, Burlington, North Carolina, USA.
Yang J; Esoterix, LabCorp, Burlington, North Carolina, USA.
Denson LA; Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Ollberding NJ; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Vinks AA; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Minar P; Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Pokaż więcej
Źródło:: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (5), pp. 524-539. Date of Electronic Publication: 2022 Oct 31.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Inflammatory Bowel Diseases*
Colitis, Ulcerative*/drug therapy
Colitis, Ulcerative*/chemically induced
Humans ; Child ; Young Adult ; Adolescent ; Treatment Outcome ; Gastrointestinal Agents ; Antibodies, Monoclonal, Humanized/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Letter: tricky reactions to switch back from subcutaneous to intravenous vedolizumab in inflammatory bowel disease patients-authors' reply.
Autorzy:: Volkers A; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Straatmijer T; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, the Netherlands.
Duijvestein M; Department of Gastroenterology, Radboud University Medical Center, Nijmegen, the Netherlands.
Löwenberg M; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
van der Meulen A; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, the Netherlands.
D'Haens G; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Pokaż więcej
Źródło:: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (6), pp. 743-744.
Typ publikacji:: Letter; Comment
MeSH Terms:: Inflammatory Bowel Diseases*
Humans ; Antibodies, Monoclonal, Humanized ; Administration, Intravenous

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Intestinal ultrasound detects an increased diameter and submucosal layer thickness in the appendix of patients with ulcerative colitis compared to healthy controls - a prospective cohort study.
Autorzy:: Reijntjes MA; Department of Surgery, Amsterdam UMC, Amsterdam, the Netherlands.; Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam, the Netherlands.
de Voogd FAE; Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam, the Netherlands.; Department of Gastroenterology and Hepatology, Amsterdam UMC, Amsterdam, the Netherlands.
Bemelman WA; Department of Surgery, Amsterdam UMC, Amsterdam, the Netherlands.; IBD Unit, Gastroenterology and Endoscopy, IRCCS Ospedale san Raffaele and University Vita-Salute San Raffaele Milano, Milano, Italy.
Hompes R; Department of Surgery, Amsterdam UMC, Amsterdam, the Netherlands.
d'Haens G; Department of Gastroenterology and Hepatology, Amsterdam UMC, Amsterdam, the Netherlands.
Buskens CJ; Department of Surgery, Amsterdam UMC, Amsterdam, the Netherlands.
Gecse KB; Department of Gastroenterology and Hepatology, Amsterdam UMC, Amsterdam, the Netherlands.; Pokaż więcej
Źródło:: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Jan; Vol. 57 (1), pp. 127-135. Date of Electronic Publication: 2022 Nov 01.
Typ publikacji:: Journal Article
MeSH Terms:: Colitis, Ulcerative*/diagnostic imaging
Ultrasonography*
Humans ; Prospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn's Disease.
Autorzy:: Elfiky AMI; Tytgat Institute for Liver and Intestinal and Research, Amsterdam Gastroenterology & Metabolism, Amsterdam University Medical Centers, University of Amsterdam, 1105 BK Amsterdam, The Netherlands.; Immunology Research Unit, GSK Medicines Research Centre, Stevenage SG1 2FX, UK.
Hageman IL; Tytgat Institute for Liver and Intestinal and Research, Amsterdam Gastroenterology & Metabolism, Amsterdam University Medical Centers, University of Amsterdam, 1105 BK Amsterdam, The Netherlands.; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Becker MAJ; Tytgat Institute for Liver and Intestinal and Research, Amsterdam Gastroenterology & Metabolism, Amsterdam University Medical Centers, University of Amsterdam, 1105 BK Amsterdam, The Netherlands.
Verhoeff J; Tytgat Institute for Liver and Intestinal and Research, Amsterdam Gastroenterology & Metabolism, Amsterdam University Medical Centers, University of Amsterdam, 1105 BK Amsterdam, The Netherlands.; Department of Molecular Cell Biology & Immunology, Amsterdam Infection & Immunity Institute and Cancer Center Amsterdam, Amsterdam University Medical Centers, Free University Amsterdam, 1081 HV Amsterdam, The Netherlands.
Li Yim AYF; Tytgat Institute for Liver and Intestinal and Research, Amsterdam Gastroenterology & Metabolism, Amsterdam University Medical Centers, University of Amsterdam, 1105 BK Amsterdam, The Netherlands.; Immunology Research Unit, GSK Medicines Research Centre, Stevenage SG1 2FX, UK.; Genome Diagnostics Laboratory, Department of Clinical Genetics, Amsterdam Reproduction & Development, Amsterdam University Medical Centers, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Joustra VW; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Mulders L; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Fung I; Tytgat Institute for Liver and Intestinal and Research, Amsterdam Gastroenterology & Metabolism, Amsterdam University Medical Centers, University of Amsterdam, 1105 BK Amsterdam, The Netherlands.
Rioja I; Immunology Research Unit, GSK Medicines Research Centre, Stevenage SG1 2FX, UK.
Prinjha RK; Immunology Research Unit, GSK Medicines Research Centre, Stevenage SG1 2FX, UK.
Smithers NN; Immunology Research Unit, GSK Medicines Research Centre, Stevenage SG1 2FX, UK.
Furze RC; Immunology Research Unit, GSK Medicines Research Centre, Stevenage SG1 2FX, UK.
Mander PK; Immunology Research Unit, GSK Medicines Research Centre, Stevenage SG1 2FX, UK.
Bell MJ; Immunology Research Unit, GSK Medicines Research Centre, Stevenage SG1 2FX, UK.
Buskens CJ; Department of Surgery, Amsterdam UMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands.
D'Haens GR; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Wildenberg ME; Tytgat Institute for Liver and Intestinal and Research, Amsterdam Gastroenterology & Metabolism, Amsterdam University Medical Centers, University of Amsterdam, 1105 BK Amsterdam, The Netherlands.
de Jonge WJ; Tytgat Institute for Liver and Intestinal and Research, Amsterdam Gastroenterology & Metabolism, Amsterdam University Medical Centers, University of Amsterdam, 1105 BK Amsterdam, The Netherlands.; Department of Surgery, University of Bonn, 53127 Bonn, Germany.; Pokaż więcej
Źródło:: Cells [Cells] 2022 Sep 12; Vol. 11 (18). Date of Electronic Publication: 2022 Sep 12.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Anti-Inflammatory Agents*/pharmacology
Anti-Inflammatory Agents*/therapeutic use
Crohn Disease*/drug therapy
Crohn Disease*/metabolism
Carboxylic Ester Hydrolases ; Humans ; Inflammation Mediators ; Interleukin-6 ; Myeloid Cells/metabolism ; NF-kappa B ; Proto-Oncogene Proteins c-akt ; RNA ; Tumor Necrosis Factor-alpha

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Peripheral Blood DNA Methylation Profiles Do Not Predict Endoscopic Post-Operative Recurrence in Crohn's Disease Patients.
Autorzy:: Joustra VW; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Li Yim AYF; Genome Diagnostics Laboratory, Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
de Bruyn JR; Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC, University of Amsterdam, 1105 BK Amsterdam, The Netherlands.
Duijvestein M; Department of Gastroenterology and Hepatology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.
Hageman IL; Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC, University of Amsterdam, 1105 BK Amsterdam, The Netherlands.
de Jonge WJ; Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC, University of Amsterdam, 1105 BK Amsterdam, The Netherlands.
Henneman P; Genome Diagnostics Laboratory, Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Wildenberg M; Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC, University of Amsterdam, 1105 BK Amsterdam, The Netherlands.
D'Haens G; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2022 Sep 09; Vol. 23 (18). Date of Electronic Publication: 2022 Sep 09.
Typ publikacji:: Journal Article
MeSH Terms:: Crohn Disease*/genetics
Crohn Disease*/surgery
DNA Methylation ; Endoscopy ; Epigenome ; Humans ; Postoperative Period ; Recurrence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases.
Autorzy:: Volkers A; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Straatmijer T; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.
Duijvestein M; Department of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands.
Sales A; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Levran A; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
van Schaik F; University Medical Centre Utrecht, Utrecht, The Netherlands.
Maljaars J; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.
Gecse K; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Ponsioen C; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Grootjans J; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Hanzel J; Department of Gastroenterology, UMC Ljubljana, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Tack G; Medical centre Leeuwarden, Leeuwarden, The Netherlands.
Jansen J; OLVG, Amsterdam, The Netherlands.
Hoentjen F; Department of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands.; Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Canada.
de Boer N; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
van der Marel S; Haaglanden Medical Centre, The Hague, The Netherlands.
Dijkstra G; University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Oldenburg B; University Medical Centre Utrecht, Utrecht, The Netherlands.
Löwenberg M; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
van der Meulen A; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.
D Haens G; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Pokaż więcej
Corporate Authors:: IBD center Amsterdam and the Dutch Initiative on Crohn and Colitis
Źródło:: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Sep; Vol. 56 (6), pp. 1044-1054. Date of Electronic Publication: 2022 Jul 23.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Colitis, Ulcerative*/chemically induced
Colitis, Ulcerative*/drug therapy
Crohn Disease*/chemically induced
Crohn Disease*/drug therapy
Inflammatory Bowel Diseases*/drug therapy
Antibodies, Monoclonal, Humanized ; Gastrointestinal Agents/therapeutic use ; Humans ; Phobic Disorders ; Prospective Studies ; Remission Induction ; Treatment Outcome
SCR Disease Name:: Belonephobia

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: A phase II, Multicentre, Randomised, Double-Blind, Placebo-controlled Study to Evaluate Safety, Tolerability, and Efficacy of Amiselimod in Patients with Moderate to Severe Active Crohn's Disease.
Autorzy:: D'Haens G; Inflammatory Bowel Disease Centre, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Danese S; Gastroenterology and Gastrointestinal Endoscopy Unit, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milano, Italy.
Davies M; Clinical Operations, Mitsubishi Tanabe Pharma Europe, London, UK.
Watanabe M; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Hibi T; Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.; Pokaż więcej
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2022 Jun 24; Vol. 16 (5), pp. 746-756.
Typ publikacji:: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:: Crohn Disease*/therapy
Propanolamines*/adverse effects
Double-Blind Method ; Fingolimod Hydrochloride/therapeutic use ; Humans ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Fibrosis and MAGNIFI-CD Activity Index at Magnetic Resonance Imaging to Predict Treatment Outcome in Perianal Fistulizing Crohn's Disease Patients.
Autorzy:: van Rijn KL; Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology, Endocrinology and Metabolism, Meibergdreef 9, Amsterdam, the Netherlands.
Meima-van Praag EM; Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology, Endocrinology and Metabolism, Meibergdreef 9, Amsterdam, the Netherlands.
Bossuyt PM; Department of Epidemiology and Data Science, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
D'Haens GR; Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology, Endocrinology and Metabolism, Meibergdreef 9, Amsterdam, the Netherlands.
Gecse KB; Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology, Endocrinology and Metabolism, Meibergdreef 9, Amsterdam, the Netherlands.
Horsthuis K; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, De Boelelaan 1117, Amsterdam, The Netherlands.
Snijder HJ; Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology, Endocrinology and Metabolism, Meibergdreef 9, Amsterdam, the Netherlands.
Tielbeek JAW; Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology, Endocrinology and Metabolism, Meibergdreef 9, Amsterdam, the Netherlands.; Department of Radiology, Spaarne Gasthuis, Haarlem, The Netherlands.
Buskens CJ; Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology, Endocrinology and Metabolism, Meibergdreef 9, Amsterdam, the Netherlands.
Stoker J; Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology, Endocrinology and Metabolism, Meibergdreef 9, Amsterdam, the Netherlands.; Pokaż więcej
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2022 Jun 24; Vol. 16 (5), pp. 708-716.
Typ publikacji:: Journal Article; Randomized Controlled Trial
MeSH Terms:: Crohn Disease*/complications
Crohn Disease*/diagnostic imaging
Crohn Disease*/drug therapy
Cutaneous Fistula*
Rectal Fistula*/diagnostic imaging
Rectal Fistula*/etiology
Rectal Fistula*/therapy
Adult ; Female ; Fibrosis ; Humans ; Magnetic Resonance Imaging ; Retrospective Studies ; Treatment Outcome ; Tumor Necrosis Factor Inhibitors ; Tumor Necrosis Factor-alpha

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Clinical, Endoscopic, and Safety Placebo Rates in Induction and Maintenance Trials of Crohn's Disease: Meta-Analysis of Randomised Controlled Trials.
Autorzy:: Almradi A; Department of Medicine, Division of Gastroenterology, Western University, London, ON, Canada.; Alimentiv Inc., London, ON, Canada.
Sedano R; Department of Medicine, Division of Gastroenterology, Western University, London, ON, Canada.; Alimentiv Inc., London, ON, Canada.
Hogan M; Alimentiv Inc., London, ON, Canada.
Zou GY; Alimentiv Inc., London, ON, Canada.; Department of Epidemiology and Biostatistics, Western University, London, ON, Canada.; Robarts Research Institute, Western University, London, ON, Canada.
MacDonald JK; Alimentiv Inc., London, ON, Canada.
Parker CE; Alimentiv Inc., London, ON, Canada.
Hanzel J; Alimentiv Inc., London, ON, Canada.; Department of Gastroenterology, UMC Ljubljana, Ljubljana, Slovenia.
Crowley E; Alimentiv Inc., London, ON, Canada.; Division of Pediatric Gastroenterology, Western University, Children's Hospital, London Health Sciences Centre, London, ON, Canada.
Singh S; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
D'Haens G; Alimentiv Inc., London, ON, Canada.; Department of Gastroenterology and Hepatology, Amsterdam UMC, Amsterdam Gastroenterology and Metabolism Research Institute, Amsterdam, The Netherlands.
Sandborn WJ; Alimentiv Inc., London, ON, Canada.; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
Feagan BG; Department of Medicine, Division of Gastroenterology, Western University, London, ON, Canada.; Alimentiv Inc., London, ON, Canada.; Department of Epidemiology and Biostatistics, Western University, London, ON, Canada.
Ma C; Alimentiv Inc., London, ON, Canada.; Division of Gastroenterology & Hepatology, Department of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada.
Jairath V; Department of Medicine, Division of Gastroenterology, Western University, London, ON, Canada.; Alimentiv Inc., London, ON, Canada.; Department of Epidemiology and Biostatistics, Western University, London, ON, Canada.; Pokaż więcej
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2022 Jun 24; Vol. 16 (5), pp. 717-736.
Typ publikacji:: Journal Article; Meta-Analysis
MeSH Terms:: Crohn Disease*/drug therapy
Humans ; Induction Chemotherapy ; Maintenance Chemotherapy ; Randomized Controlled Trials as Topic ; Remission Induction

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Association Between Proposed Definitions of Clinical Remission/Response and Well-Being in Patients With Crohn's Disease.
Autorzy:: Sandborn WJ; University of California San Diego, La Jolla, CA, USA.
Lewis JD; University of Pennsylvania, Philadelphia, PA, USA.
Panes J; Hospital Clínic Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
Loftus EV; Mayo Clinic, Rochester, MN, USA.
D'Haens G; Amsterdam University Medical Centers, Amsterdam, Netherlands.
Yu Z; AstraZeneca, Chicago, IL, USA.
Huang B; AbbVie Inc., North Chicago, IL, USA.; AstraZeneca, Chicago, IL, USA.
Lacerda AP; AbbVie Inc., North Chicago, IL, USA.
Pangan AL; AbbVie Inc., North Chicago, IL, USA.
Feagan BG; Robarts Clinical Trials, London, ON, Canada.; Pokaż więcej
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2022 Mar 14; Vol. 16 (3), pp. 444-451.
Typ publikacji:: Journal Article; Randomized Controlled Trial
MeSH Terms:: Crohn Disease*/drug therapy
Abdominal Pain ; Adalimumab/therapeutic use ; Double-Blind Method ; Humans ; Patient Reported Outcome Measures

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's disease.
Autorzy:: Colman RJ; Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Xiong Y; Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Mizuno T; Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.; University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Hyams JS; Gastroenterology, Hepatology and Nutrition, Connecticut Children's Medical Center, Hartford, CT, USA.
Noe JD; Gastroenterology, Hepatology and Nutrition, Children's Hospital of Wisconsin, Milwaukee, WI, USA.
Boyle B; Gastroenterology, Hepatology and Nutrition, Nationwide Children's Hospital, Columbus, OH, USA.
D'Haens GR; Gastroenterology and Hepatology, Amsterdam UMC, Amsterdam, The Netherlands.
van Limbergen J; Pediatric Gastroenterology, Emma Children's Hospital, Amsterdam UMC, Amsterdam, The Netherlands.
Chun K; Esoterix, LabCorp, Calabasas Hills, CA, USA.
Yang J; Esoterix, LabCorp, Calabasas Hills, CA, USA.
Rosen MJ; Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.; University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Denson LA; Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.; University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Vinks AA; Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.; University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Minar P; Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.; University of Cincinnati College of Medicine, Cincinnati, OH, USA.; Pokaż więcej
Źródło:: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Mar; Vol. 55 (5), pp. 593-603. Date of Electronic Publication: 2021 Dec 22.
Typ publikacji:: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Crohn Disease*
Antibodies ; Child ; Gastrointestinal Agents/therapeutic use ; Humans ; Infliximab ; Prospective Studies
SCR Disease Name:: Pediatric Crohn's disease

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Systematic Review and Meta-Analysis: Clinical, Endoscopic, Histological and Safety Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis.
Autorzy:: Sedano R; Division of Gastroenterology, Department of Medicine, Western University, London, Ontario, Canada.; Alimentiv Inc., London, Ontario, Canada.
Hogan M; Alimentiv Inc., London, Ontario, Canada.
Nguyen TM; Alimentiv Inc., London, Ontario, Canada.
Chang J; Alimentiv Inc., London, Ontario, Canada.
Zou GY; Alimentiv Inc., London, Ontario, Canada.; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.
Macdonald JK; Alimentiv Inc., London, Ontario, Canada.
Vande Casteele N; Alimentiv Inc., London, Ontario, Canada.; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
Hanzel J; Alimentiv Inc., London, Ontario, Canada.; Department of Gastroenterology, UMC Ljubljana, Ljubljana, Slovenia.
Crowley E; Alimentiv Inc., London, Ontario, Canada.; Division of Pediatric Gastroenterology, Western University, Children's Hospital, London Health Sciences Centre, London, Ontario, Canada.
Battat R; Jill Roberts Center for IBD, Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, NY, USA.
Dulai PS; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
Singh S; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
D'Haens G; Alimentiv Inc., London, Ontario, Canada.; Department of Gastroenterology and Hepatology, Amsterdam UMC, Amsterdam Gastroenterology and Metabolism Research Institute, University of Amsterdam, Amsterdam, The Netherlands.
Sandborn W; Alimentiv Inc., London, Ontario, Canada.; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
Feagan BG; Division of Gastroenterology, Department of Medicine, Western University, London, Ontario, Canada.; Alimentiv Inc., London, Ontario, Canada.; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.
Ma C; Alimentiv Inc., London, Ontario, Canada.; Division of Gastroenterology & Hepatology, Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
Jairath V; Division of Gastroenterology, Department of Medicine, Western University, London, Ontario, Canada.; Alimentiv Inc., London, Ontario, Canada.; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.; Pokaż więcej
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2022 Feb 23; Vol. 16 (2), pp. 224-243.
Typ publikacji:: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:: Colitis, Ulcerative*/drug therapy
Adult ; Humans ; Immunosuppressive Agents/therapeutic use ; Induction Chemotherapy ; Maintenance Chemotherapy ; Remission Induction

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: The Role of the Lymphatic System in the Pathogenesis and Treatment of Inflammatory Bowel Disease.
Autorzy:: Nikolakis D; Department of Gastroenterology, Amsterdam Institute for Gastroenterology Endocrinology and Metabolism, Academic Medical Center, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.; Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology & Immunology Center (ARC), Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Institute for Infection & Immunity, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.; Onassis Foundation, 4 Aeschinou Street, 10558 Athens, Greece.
de Voogd FAE; Department of Gastroenterology, Amsterdam Institute for Gastroenterology Endocrinology and Metabolism, Academic Medical Center, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Pruijt MJ; Department of Gastroenterology, Amsterdam Institute for Gastroenterology Endocrinology and Metabolism, Academic Medical Center, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Grootjans J; Department of Gastroenterology, Amsterdam Institute for Gastroenterology Endocrinology and Metabolism, Academic Medical Center, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
van de Sande MG; Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology & Immunology Center (ARC), Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Institute for Infection & Immunity, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
D'Haens GR; Department of Gastroenterology, Amsterdam Institute for Gastroenterology Endocrinology and Metabolism, Academic Medical Center, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2022 Feb 06; Vol. 23 (3). Date of Electronic Publication: 2022 Feb 06.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Inflammatory Bowel Diseases/*pathology
Lymph Nodes/*immunology
Lymphatic System/*immunology
Adaptive Immunity ; Animals ; Humans ; Immunity, Innate ; Inflammatory Bowel Diseases/immunology ; Quality of Life

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised Trial.
Autorzy:: Vermeire S; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
D'Haens G; Department of Gastroenterology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Baert F; Department of Gastroenterology, AZ Delta, Roeselare, Belgium.
Danese S; Humanitas Clinical and Research Center - IRCCS, and Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Kobayashi T; Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
Loftus EV; Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Bhatia S; Takeda, Cambridge, MA, USA.
Agboton C; Takeda, Zurich, Switzerland.
Rosario M; Takeda, Cambridge, MA, USA.
Chen C; Takeda, Cambridge, MA, USA.
Zhang W; Takeda, Cambridge, MA, USA.
Kisfalvi K; Takeda, Cambridge, MA, USA.
Sandborn WJ; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.; Pokaż więcej
Źródło:: Journal of Crohn's & colitis [J Crohns Colitis] 2022 Jan 28; Vol. 16 (1), pp. 27-38.
Typ publikacji:: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
MeSH Terms:: Antibodies, Monoclonal, Humanized/*administration & dosage
Crohn Disease/*drug therapy
Gastrointestinal Agents/*administration & dosage
Administration, Intravenous ; Adult ; Double-Blind Method ; Female ; Humans ; Injections, Subcutaneous ; Maintenance Chemotherapy ; Male ; Quality of Life ; Remission Induction

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""D'Haens, Geert"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język